spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Oxymorphone 

 HSMN NewsFeed - 7 Aug 2017
Impax Announces Settlement of Contract Litigation on Opana(R) ER (Oxymorphone Hydrochloride) CII Extended-Release Tablets
Biopharmaceuticals Litigation
 HSMN NewsFeed - 26 Apr 2017
Inspirion Delivery Sciences Receives FDA Approval for RoxyBond(TM) (oxycodone hydrochloride) tablets CII, the First and Only Immediate Release Opioid Analgesic with Abuse-Deterrent Label Claims
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 13 Aug 2015
BioDelivery Sciences Announces FDA Approval of New Formulation of ONSOLIS(R) (fentanyl buccal soluble film) CII
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 22 Oct 2013
Pfizer Proceeding with REMOXY(R) Development
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 26 Aug 2011
NUCYNTA(R) ER (Tapentadol Extended-Release Tablets) Receives FDA Approval for the Management of Moderate to Severe Chronic Pain
Biopharmaceuticals FDA
 HSMN NewsFeed - 10 Feb 2011
Covidien Receives FDA Approval for Fentanyl Transdermal System Patch
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 14 May 2010
Impax Laboratories Receives Tentative FDA Approval for Generic Opana(R) ER 5, 7.5, 10, 15, 20, 30 and 40 mg Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 13 Apr 2010
Penwest and Endo Enter Into Agreement With Barr to Settle Patent Litigation Over Opana(R) ER
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 2 Mar 2010
FDA Approves EXALGO (Hydromorphone HCL) Extended-Release Tablets
Biopharmaceuticals FDA
 HSMN NewsFeed - 13 Oct 2009
Meda Launches Onsolis(TM) (Fentanyl Buccal Soluble Film) for the Treatment of Breakthrough Cancer Pain in Opioid Tolerant Patients
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 6 May 2008
Cephalon Announces FDA Advisory Committee Recommendation Against Approval of an Expanded Label for FENTORA
Biopharmaceuticals FDA
 HSMN NewsFeed - 3 Mar 2008
Endo Pharmaceuticals to Launch Three New Dosage Strengths of OPANA(R) ER
Biopharmaceuticals Pain Management FDA
 HSMN NewsFeed - 19 Nov 2007
IMPAX Comments on Lawsuit Related to Generic Version of Opana(R) ER
Biopharmaceuticals Litigation
 HSMN NewsFeed - 15 Nov 2007
Endo and Penwest File Lawsuit Against IMPAX Laboratories Relating to OPANA(R) ER
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 13 Sep 2007
Cephalon Reinforces Important Prescribing and Dosing Information for FENTORA
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 16 Aug 2007
Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 17 Jul 2007
Penwest Enters Into Collaboration Agreement With Edison Pharmaceuticals
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 2 May 2007
Penwest Names Amale Hawi Senior Vice President, Pharmaceutical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 May 2007
Cephalon Presents Positive Results for FENTORA(R) in Breakthrough Pain Associated with Neuropathic Conditions
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 9 Jan 2007
Cephalon Announces Positive Results from Two Phase 3 Clinical Trials of FENTORA(TM) in Breakthrough Pain
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 8 Jan 2007
Cephalon Announces Positive Results from Two Phase 3 Clinical Trials of FENTORA(TM) in Breakthrough Pain
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 8 Jan 2007
Endo and Penwest Agree to Amend Opana(R) ER Contract
Biopharmaceuticals
 HSMN NewsFeed - 11 Oct 2006
Cephalon Announces Positive Results for FENTORA(TM) (fentanyl buccal tablet) for Breakthrough Pain in Patients with Chronic Low Back Pain
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 25 Sep 2006
Cephalon Receives FDA Approval of FENTORA(TM) (fentanyl buccal tablet) for the Management of Breakthrough Pain in Patients with Cancer
Biopharmaceuticals Oncology Drug Delivery FDA
 HSMN NewsFeed - 24 Jul 2006
Endo Announces Commercial Availability of Opana(R) ER (oxymorphone HCl) Extended-Release and Opana(R) (oxymorphone HCl) Immediate-Release Tablets CII
Biopharmaceuticals
 HSMN NewsFeed - 23 Jun 2006
Penwest Announces That Endo Reports Receiving Final FDA Approval for Oxymorphone ER
Biopharmaceuticals
 HSMN NewsFeed - 23 Jun 2006
Endo Receives FDA Approval for Opana(R) ER (oxymorphone HCl) Extended-Release and Opana(R) (oxymorphone HCl) Immediate Release Tablets CII
Biopharmaceuticals FDA
Return to NewsFeed  

 Additional items found! 18

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 18 additional stories matching:
Oxymorphone
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.